期刊文献+

帕罗西汀中间体还原反应工艺研究

Study on the Reduction Reaction Process of Paroxetine Intermediate
下载PDF
导出
摘要 研究了硼氢化钠-甲醇-叔丁醇体系将帕罗西汀中间体(4-(4-氟苯基)-3-乙氧羰基-1-甲基哌啶-2,6-二酮)进行还原的反应,分别考察了还原催化体系、温度和投料比等条件对反应收率的影响。结果表明,以叔丁醇作溶剂,甲醇做催化剂,原料二酮、硼氢化钠的摩尔比为1:5.5,反应温度50℃下反应2 h,收率88%。该工艺具有收率较高、工艺简单和环境友好等特点,具有较好的产业化应用前景。 The paroxetine intermediate(4-(4-fluorophenyl)-3-ethoxy-1-methylpiperidine-2,6-dione) was reduced by the catalytic system of sodium borohydride-methanol-t-butyl alcohol. Then, the effect of reduction reaction conditions such as reduction catalysts system, temperature and feed ratio on the reaction yield were mainly discussed. The results showed that 88% yield of product was gotten in 2 h, with t-butyl alcohol as solvent, methanol as co-catalyst, the molar to its advantages such as good yield, simple process, and environmental friendly. ratio of raw material dione and sodium borohydride was 1:5.5, and the reaction temperature was 50℃.The progress has better prospect for industrial application due.
出处 《化工生产与技术》 CAS 2016年第3期31-32,38,共3页 Chemical Production and Technology
关键词 4-(4-氟苯基)-3-乙氧羰基-1-甲基哌啶-2 6-二酮 帕罗西汀 硼氢化钠-叔丁醇-甲醇 还原 4-(4-fluorophenyl)-3-ethoxy-1-methylpiperidine-2,6-dione paroxetine sodium borohydride-t-butyl alcohol-methanol reduction
  • 相关文献

参考文献2

二级参考文献18

  • 1Higgime P G,Tyrell D A.Chiral Resolving Agent and Biocatalysts in Organic Syntheses Elsevier[J].Org.Chem,1993,53:2 643.
  • 2Robin R K.Synthesis of Paroxetine[P].CS:233 275,1996-03-21.
  • 3Austin S.Diagnosis & Treatment and Prescribe of Paroxetine[P].DE:3 238 530,1999-03-12.
  • 4Somito K.A process for the Preparation of 3-Ethoxycarbonyl-1-methyl Piperdine-2,6-dione Derivatives as Intermediates for Drugs[P].JP:42 151 631,1989-09-18.
  • 5Senga K,Nishigaki S.Preparation of N-methylaminocarbonyl-acetate Derivatives as Herbicides[J].Am.Chem.Soc.,1989,213 (1):103.
  • 6唐培堃.中间体化学工艺学[M].北京:化学工业出版社出版,1984.132-133.
  • 7何泽人编译.无机工艺化学合成手册·增订版[M].北京:化学工业出版社,1960.113-114.
  • 8Blier P. The pharmacology of putative early-onset antidepressant strategies[J]. Eur Neuropsychopharmacol, 2003, 13(2): 57- 66.
  • 9Pearce EF, Murphy JA. Vortioxetine for the treatment of depression[J]. Ann Pharmacother, 2014, 48(6): 758-765.
  • 10Mago R, Mahajan R, Thase ME. Levomilnacipran: a newly approved drug for treatment of major depressive disorder[J]. Expert Rev Clin Pharmacol, 2014, 7(2): 137-145.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部